|
🐜
|
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
32 auth.
F. Le Loarer,
S. Watson,
G. Pierron,
V. D. De Montpreville,
S. Ballet,
N. Firmin,
A. Auguste,
D. Pissaloux,
S. Boyault,
S. Paindavoine,
P. Dechelotte,
B. Besse,
J. Vignaud,
M. Brevet,
E. Fadel,
...
W. Richer,
I. Treilleux,
J. Masliah-Planchon,
M. Devouassoux-Shisheboran,
G. Zalcman,
Y. Allory,
F. Bourdeaut,
F. Thivolet-Béjui,
D. Ranchère‐Vince,
N. Girard,
S. Lantuejoul,
F. Galateau-Salle,
J. Coindre,
A. Leary,
O. Delattre,
J. Blay,
F. Tirode
|
8 |
2015 |
8
🐜
|
|
🐜
|
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.
38 auth.
O. Trédan,
Q. Wang,
D. Pissaloux,
P. Cassier,
A. Fouchardière,
J. Fayette,
F. Desseigne,
I. Ray-Coquard,
C. Fouchardiere,
Didier Frappaz,
P. Heudel,
A. Bonneville-Levard,
A. Fléchon,
M. Sarabi,
P. Guibert,
...
T. Bachelot,
M. Pérol,
Benoit You,
N. Bonnin,
O. Collard,
C. Leyronnas,
V. Attignon,
C. Baudet,
E. Sohier,
J. Villemin,
A. Viari,
S. Boyault,
S. Lantuejoul,
S. Paindavoine,
I. Treillleux,
C. Rodriguez,
V. Agrapart,
V. Corset,
G. Garin,
S. Chabaud,
D. Pérol,
J. Blay,
ProfiLER investigators
|
7 |
2019 |
7
🐜
|
|
🐜
|
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
20 auth.
Mathilde Small,
I. Treilleux,
C. Couillault,
D. Pissaloux,
G. Picard,
S. Paindavoine,
V. Attignon,
Qing Wang,
V. Rogemond,
S. Lay,
...
I. Ray-Coquard,
J. Pfisterer,
F. Joly,
A. du Bois,
D. Psimaras,
N. Bendriss-Vermare,
C. Caux,
B. Dubois,
J. Honnorat,
V. Desestret
|
6 |
2018 |
6
🐜
|
|
🐜
|
Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp
16 auth.
S. Costa,
M. Byrne,
D. Pissaloux,
V. Haddad,
S. Paindavoine,
L. Thomas,
F. Aubin,
T. Lesimple,
F. Grange,
B. Bonniaud,
...
L. Mortier,
C. Mateus,
B. Dréno,
B. Balme,
B. Vergier,
A. de la Fouchardière
|
6 |
2016 |
6
🐜
|
|
🐜
|
Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
26 auth.
B. Dadone-Montaudié,
L. Alberti,
A. Duc,
Lucile Delespaul,
T. Lesluyes,
Gaëlle Pérot,
A. Lançon,
S. Paindavoine,
I. Di Mauro,
J. Blay,
A. de la Fouchardière,
F. Chibon,
M. Karanian,
G. MacGrogan,
V. Kubiniek,
...
Frédérique Keslair,
N. Cardot-Leccia,
A. Michot,
V. Perrin,
Yanis Zekri,
J. Coindre,
F. Tirode,
F. Pedeutour,
D. Ranchère‐Vince,
F. Le Loarer,
D. Pissaloux
|
5 |
2018 |
5
🐜
|
|
🐜
|
Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis
25 auth.
Nicolas Macagno,
D. Pissaloux,
A. de la Fouchardière,
M. Karanian,
S. Lantuejoul,
F. Galateau Salle,
A. Meurgey,
C. Chassagne‐Clément,
I. Treilleux,
C. Renard,
Juliette Roussel,
Julie Gervasoni,
Vincent Cockenpot,
C. Crozes,
Aline Baltrès,
...
Aurélie Houlier,
S. Paindavoine,
L. Alberti,
A. Duc,
F. Loarer,
A. Dufresne,
M. Brahmi,
N. Corradini,
J. Blay,
F. Tirode
|
5 |
2022 |
5
🐜
|
|
🐜
|
Superficial CD34‐positive fibroblastic tumor and PRDM10‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases
18 auth.
R. Perret,
M. Michal,
R. Carr,
V. Vélasco,
M. Švajdler,
M. Karanian,
A. Meurgey,
S. Paindavoine,
I. Soubeyran,
J. Coindre,
...
R. Boidot,
C. Charon-Barra,
Damien Geneste,
N. Weingertner,
D. Pissaloux,
F. Tirode,
Jessica Baud,
F. Le Loarer
|
5 |
2021 |
5
🐜
|
|
🐬
|
CYSLTR2-mutant Cutaneous Melanocytic Neoplasms Frequently Simulate “Pigmented Epithelioid Melanocytoma,” Expanding the Morphologic Spectrum of Blue Tumors
K. Goto,
D. Pissaloux,
S. Paindavoine,
F. Tirode,
A. de la Fouchardière
|
4 |
2019 |
4
🐬
|
|
🐜
|
SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors
13 auth.
M. Karanian,
A. Kelsey,
S. Paindavoine,
A. Duc,
H. Vanacker,
L. Hook,
N. Weinbreck,
C. Delfour,
V. Minard,
Pauline Baillard,
...
J. Blay,
D. Pissaloux,
F. Tirode
|
4 |
2020 |
4
🐜
|
